R&D Integration Partner Launch Research Services for Life Sciences

Symyx Technologies, Inc has announced the launch of its new client-directed and collaborative research services for Life Sciences. These services allow clients to access Symyx`s installed base of parallel
experimentation and testing capabilities through packaged offerings for solubility studies, polymorph screening, salt selection, co-crystallisation, API stability in liquid and solid formulations, excipient compatibility, organic synthesis and process optimisation. Symyx recently signed a one year agreement with Bristol-Myers Squibb
Company for the use of Symyx Research Services for solubility studies. Under terms of the agreement, Symyx will perform solubility studies for Bristol-Myers Squibb through until May 2009. “Symyx Research is continuing to transform its offerings into packaged, smaller scope
and easily accessible solutions. Symyx Research Services combines our industryleading research capabilities with real-time data analysis to deliver results on demand, freeing companies from internal capability
constraints while substantially reducing the cost of R&D,” said Richard Boehner, President of Symyx Research.

Symyx Research Services offer considerable programme flexibility with contracts ranging from a single experiment screen up to tens-of-thousands of experiments per year. Customers also benefit from access to Symyx`s capability to execute and analyse hundreds of experiments quickly and to deliver results in days not months.

Symyx Research Services provides greater experimental insight through development of more comprehensive data sets through automated parallel experimentation than can be achieved through traditional manual processes. Symyx Research Services also provide seamless replication
of data and results to an existing customermanaged Symyx database and dynamic access to data sets using Symyx Software, which allows evaluation of full and raw data sets not static PDF reports.